Fibrocell Science (FCSC) Tops Q4 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to Fibrocell Science (FCSC) Tops Q4 EPS by 8c

Fibrocell Science Reports Fourth Quarter and Full Year 2014 Financial and Operating Results

March 13, 2015 8:10 AM EDT

- Significant progress advancing gene therapy candidate for recessive dystrophic epidermolysis bullosa (RDEB), a devastating and progressive orphan skin disease -

- Phase II clinical trial progressing for vocal cord scarring -

- Company to Host Conference Call and Webcast, Today at 8:30 a.m. EDT -

EXTON, Pa., March 13, 2015 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (Nasdaq: FCSC), an autologous cell therapy company primarily focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet... More